<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/082E3C1A-59C5-4E8A-BBC9-AB9D3571AE75"><gtr:id>082E3C1A-59C5-4E8A-BBC9-AB9D3571AE75</gtr:id><gtr:name>Sanford Burnham Medical Research Inst</gtr:name><gtr:address><gtr:line1>10901 North Torrey Pines Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/082E3C1A-59C5-4E8A-BBC9-AB9D3571AE75"><gtr:id>082E3C1A-59C5-4E8A-BBC9-AB9D3571AE75</gtr:id><gtr:name>Sanford Burnham Medical Research Inst</gtr:name><gtr:address><gtr:line1>10901 North Torrey Pines Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C4C94958-93C0-42D3-9370-4F43D57329E4"><gtr:id>C4C94958-93C0-42D3-9370-4F43D57329E4</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Schwabe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3773CC94-6B1D-43AC-A76E-F6A14D9B05CC"><gtr:id>3773CC94-6B1D-43AC-A76E-F6A14D9B05CC</gtr:id><gtr:firstName>Shaun</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Cowley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ009598%2F1"><gtr:id>69107990-B92C-4994-BE05-8925FA935498</gtr:id><gtr:title>Understanding the recruitment of Class I HDACs into diverse repression complexes: implications for physiological activity and therapeutic devlopment</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/J009598/1</gtr:grantReference><gtr:abstractText>'Histone deacetylase' (HDAC) enzymes are present in all cells of the body. Their function is to switch genes 'off', and make sure they stay 'off'. My lab studies how HDACs do this and which, amongst the 25,000 genes in each cell, are selected for inactivation. HDAC enzymes also represent an exciting medical opportunity because they are 'druggable'. Already, drugs which inhibit HDAC activity are being used in the clinic as anti-cancer agents, and are being further developed for their beneficial effects on dementia and anti-inflammatory properties. There is therefore a compelling applied, as well as academic, motivation for studying their physiological roles in order to assess their potential as pharmacological targets. We intend to study how three different HDAC enzymes (HDACs 1, 2 and 3) work in normal cells. One of the best methods for understanding how an enzyme works is to generate mutant cells in which the specific enzyme has been inactivated, or 'knocked-out'. These 'knock-out' cells can then be examined for changes in their characteristics, lack of growth for instance, which can then be attributed to the function of that particular enzyme. Previously, we have generated 'knock-out' cells for HDAC1 and HDAC2 alone, but their function is overlapping, and so the effects on cell growth were small. To get around this, we have generated cells in which HDAC1 and 2 can be removed at the same time, so called 'double knock-out' cells. Early experiments indicate that loss of both enzymes causes cells to die, indicating that their activity is essential. Using DNA technology it is possible to add back normal or mutated forms of HDAC1 to prevent the double knock-out cells from dying and then ask, which parts of the enzyme are important for its function? In related experiments, we also intend to visualize the actual molecular structure of HDAC1 bound to a molecule called MTA1, using a technique called X-ray crystallography. The interaction of HDAC1 with other molecules in the cell is fundamental to their function. By understanding the molecular basis of these interactions we can better understand how HDAC enzymes work in normal and cancer cells, and potentially use that knowledge to design new drugs to prevent them from working. The ability to stop HDAC1 and 2 from working, as seen in our double knock-out cells, causes cells to stop growing and die, making them excellent drug targets in the search for improved anti-cancer agents.</gtr:abstractText><gtr:technicalSummary>Class-1 histone deacetylases (HDACs 1, 2, 3 and 8) are essential enzymes present in the nucleus of all mammalian cells where they help regulate chromatin structure as the catalytic component of co-repressor complexes such as Sin3A, NuRD, CoREST and SMRT. The function of HDACs in vivo is dependent upon recruitment into specific multi-protein co-repressor complexes, which regulate both substrate specificity and enzymatic activity. Despite this, little attention has been paid to the molecular assembly of individual complex components, and in particular there are no structural data to explain the specificity of assembly. We aim to combine in vivo (Cowley lab) and structural (Schwabe lab) approaches to understand the molecular determinants of HDAC1/2 recruitment to the Sin3A, NuRD and CoREST complexes, identify areas of similarity and diversity between these different complexes and understand how specificity is maintained so as to exclude the highly related enzyme, HDAC3. To address these questions we have three specific objectives: Objective 1: Using the known structures of HDAC2 and HDAC3 we will design mutations to map the Sin3A/MTA1/CoREST1 interaction surface(s) of HDAC1 and 2. Objective 2: Determine structures of the HDAC1/2 interaction domains of Sin3A, MTA1 and CoREST1, with and without HDAC1/2, using NMR and X-ray crystallographic approaches. Objectives 1 and 2 will run simultaneously and are highly interdependent. Both approaches will identity critical residues in HDAC1/2 required for complex incorporation. Objective 3: We will make mutations in these critical residues and test their importance for the physiological activity of HDAC1/2 by testing their ability to rescue the viability of HDAC1/2 double knock-out ES cells (part i), and be recruited to target genes (part ii). This work will directly establish the molecular determinants of HDAC1/2 complex assembly and to what degree this determines their physiological activity</gtr:technicalSummary><gtr:potentialImpactText>1. Commercial / Industrial - 
There is a growing awareness within the pharmaceutical industry of histone modifying enzymes as potential drug targets. HDAC1 and 2 function has been implicated in almost all cellular processes including, cell cycle progression, DNA repair, differentiation and cancer. Furthermore, mouse knock-out studies have demonstrated that HDAC1/2 have essential roles in the development of the heart, neurons, skin and B-cells. Given these essential biological roles, HDAC1 and 2 enzymes are strong candidates for pharmacological manipulation. The novel structural data of HDAC:co-repressor complexes, coupled to the physiological validation of key determinants, will be of great value in the design of conventional HDAC inhibitors (focussed on the active site); and the long-term goal of using small molecules to inhibit the protein-protein interactions of these complexes to perturb HDAC1/2 function. The University of Leicester has a vigorous and experienced &amp;quot;Enterprise &amp;amp; Business Development&amp;quot; team and an embedded unit (&amp;quot;The Biobator&amp;quot;), dedicated to exploitation of activities arising from work in biomedical research. Outputs from the project will be used by BIOBATOR to establish partnerships with industrial collaborators to exploit these findings. 

2. Societal - 
Inhibitors of HDAC1 and 2 are currently used in the clinic to treat depression and cancer. It is only a matter of time before their application becomes more extensive, enhancing the well-being of society as a whole. In the laboratory, inhibition of HDAC1 and 2 reactivates alpha-globin (the foetal globin isoform) in human erythroid progenitors, making them potential therapeutic targets for the treatment of sickle cell disease. Inhibition of HDAC activity has ameliorative effects in mice models of dementia and muscular dystrophy. The essence of our project is basic science, and the therapeutic payoff long-term. However, an understanding of HDAC enzymes in their cellular context, incorporated into diverse co-repressor complexes, will be necessary to understand the action of existing HDACi used clinically, and in the design of small molecules which inhibit HDAC function. 

3. Animal Welfare - 3R's.
Reduction, refinement and replacement (3R's) of animals in experimental research is a commitment made by each of the research councils and major research institutes within the United Kingdom. This project will use cells with an inducible knock-out of HDAC1 and 2 (Objective 3), which were generated using 'embryo free' methodology. This contrasts with the traditional method of generating knock-out cell lines from mouse embryos. Recently, the large scale production of knock-out mice embryonic stem (ES) cell lines was begun by the KOMP (Knock-out Mouse Project) and EUCOMM (European Community Mutant Mouse project) consortia, in their attempt to make a mutant cell line for every protein-coding gene in the mouse genome. The KO cells generated by these schemes will be made freely available to the academic community. This project will promote the same ES cell knock-out technology, their suitability for study of gene expression and raise awareness of this alternative to animal based systems.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>445695</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Chromsome segregation in HDAC1/2 DKO cells</gtr:description><gtr:id>59F93A29-AD8A-4480-B40A-A625F8E270C7</gtr:id><gtr:impact>This collaboration was instrumental in the publication of Jamaladdin et al. (2014) in PNAS</gtr:impact><gtr:outcomeId>54639de7ad6829.87187640-1</gtr:outcomeId><gtr:partnerContribution>The Fry lab was able to take HDAC1/2 DKO cells and quantitate aberrant chromosome segregation using an immunofluoresence microscopy approach.</gtr:partnerContribution><gtr:piContribution>We provided HDAC1/2 double knocjout cells to the Fry lab for them to analyze chromosome segregation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanford-Burnham Medical Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Understanding the role of HDAC3 in stem cell differentiation</gtr:description><gtr:id>F963BB41-6E5D-4918-AE0F-A01EC04CF525</gtr:id><gtr:impact>A manuscript &amp;quot;Oct4 acts as an integrator of pluripotency and signal-induced differentiation&amp;quot; has recently been written and submitted.</gtr:impact><gtr:outcomeId>56dd746fc4c923.18344871-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators have used our cells to confirm the role of the HDAC3/SMRT co-repressor complex in early embryonic stem cell differentiation.</gtr:partnerContribution><gtr:piContribution>We have generated a conditional HDAC3 knock-out cell line which has been used in ChIP-seq to examine the relations ship between retinoid signalling and the pluripotent factor Oct4.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>STEM ambassador</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DB8764DB-9A60-4388-A2D7-6034867A3F8B</gtr:id><gtr:impact>In 2015 I registered as a STEM (Science, Technology, Engineering and Mathematics Network) ambassador in the East Midlands network and through the activities of the Leicestershire Education Business Company. I participated in a 'walking careers library' at Lancaster Boys school in Leicester - the idea is that the boys have the opportunity to walk around the hall and meet with and discuss possible careers with adults from different sectors. The event took place with the whole of Year 9 (approx. 180 pupils) following on from their careers assembly</gtr:impact><gtr:outcomeId>56dd76fb50c669.90243262</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.leics-ebc.org.uk/</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School talks - Animals in Research (UoL)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>78677D40-AD8D-4A6E-B8DB-C816B28B6D5C</gtr:id><gtr:impact>As part of the outreach activities at the Animal Facility at the University of Leicester I have given talks to school children and their teachers about the practical, ethical and legal issues surrounding the use of animals in research.</gtr:impact><gtr:outcomeId>56dd7795a8a056.65715497</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Host Yr10 work placement student</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BF2A1B2B-5A16-4FAF-B7B0-F9B33D0EB773</gtr:id><gtr:impact>My lab has hosted a year 10 work placement student annually since 2014. The student works as a research technician in the lab for 2 weeks as part of work experience programme.</gtr:impact><gtr:outcomeId>56dd783b781849.96712708</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014,2015,2016,2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2055742</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior non-Clinical Fellowship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J009202/1</gtr:fundingRef><gtr:id>CAC74BA6-5958-4FFA-A6E7-413BD5620A7F</gtr:id><gtr:outcomeId>rTQSVcVCtv9</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>507944</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC - Project Grant 2016-18</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/N002954/1</gtr:fundingRef><gtr:id>843E5B72-F145-4EAF-AB8D-F7E1967BDE62</gtr:id><gtr:outcomeId>56dd7a76953360.65019239</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have shown that the enzymes HDAC1 and HDAC2 are essential for the growth of embryonic stem cells. In addition, that HDAC enzymes are regulated by the presence of an external signaling molecule called inositol phosphate.</gtr:description><gtr:exploitationPathways>Histone deacetylase (HDAC) enzymes are essential enzymes for the growth of normal cells. Inhibitors of HDAC enzymes are used to block the growth of cancer cells and to treat patients with bi-polar disorder, although it is far from clear how they work in vivo. We have added to the knowledge of HDAC enzymes in their role in cell cycle and how they can be regulated by external signaling pathways.</gtr:exploitationPathways><gtr:id>DF0A937A-9A9F-417B-9F59-C8BAB5C4F3AE</gtr:id><gtr:outcomeId>5463a01a98d933.02992164</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We present a novel recombineering methodology of vector assembly using a multiplex approach. Plasmid gap repair is performed by the simultaneous capture of genomic sequence from mouse Bacterial Artificial Chromosome libraries and the insertion of dual bacterial and mammalian selection markers. This single-step multiplex recombineering method is highly efficient and yields a majority of correct recombinants. We present data for the construction of different types of conditional gene knockout, or knock-in, vectors and BAC reporter vectors that have been constructed using this method. Multiplex recombineering greatly extends the repertoire of the recombineering toolbox and provides a simple, rapid and cost-effective method of constructing these highly complex vectors.</gtr:description><gtr:id>A9089004-D08C-4CEF-8C85-B6A5F9672A7D</gtr:id><gtr:impact>This method will be published in the Journal of Visual Experiments in 2014</gtr:impact><gtr:outcomeId>54639c727a0282.08567610</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Multiplex recombineering: a one-step method for vector construction in gene targeting applications</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We describe a simple and accessible method for expressing and purifying milligram quantities of protein by performing transient transfections of suspension grown HEK (Human Embryonic Kidney) 293F cells.</gtr:description><gtr:id>84DFD8B6-16F1-43BB-B855-BFE926895822</gtr:id><gtr:impact>This improved method of producing protein complexes in mammlian cells was published in the Journal of Visual Experiemtns in 2014.</gtr:impact><gtr:outcomeId>54639bfa7007a5.72674754</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.jove.com/video/51897/recombinant-protein-expression-for-structural-biology-hek-293f</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Embryonic stem cells in which Hdac1 and Hdac2 can be deleted simultaneously following addition of Tamoxifen.</gtr:description><gtr:id>D9533BD6-9A0B-4783-B311-3F5EC80CF6C3</gtr:id><gtr:impact>These cells have been published by my own group, Jamaladdin et al. (2014) PNAS and have been provided to our collaborator Georges Lacaud at the Patterson Institute in Manchester.</gtr:impact><gtr:outcomeId>54639b057619e6.15533334</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Hdac1/Hdac2 Double conditional knock-out ES cells</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3A66EAAC-E0C9-4FFD-8CD6-94DB06C38389</gtr:id><gtr:title>GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/389fbc17670ddcf503e58462dcef63e6"><gtr:id>389fbc17670ddcf503e58462dcef63e6</gtr:id><gtr:otherNames>Thambyrajah R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>56dd70178c2284.45399322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>751B0BBF-CDCE-4272-A4F8-FCE73B9221AC</gtr:id><gtr:title>The structure of the core NuRD repression complex provides insights into its interaction with chromatin.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/345fba85d7717caf1056a737fa6e15cc"><gtr:id>345fba85d7717caf1056a737fa6e15cc</gtr:id><gtr:otherNames>Millard CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>585d701ad5f1e8.59934567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A425DC1A-55D0-47EF-B234-D0BB51FA3AAD</gtr:id><gtr:title>Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bd1c7b42539f1fb8b1265193623edc0"><gtr:id>3bd1c7b42539f1fb8b1265193623edc0</gtr:id><gtr:otherNames>Jamaladdin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_540e193e193f14838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>829F09A5-6820-4C11-B833-27A6CE885EFF</gtr:id><gtr:title>Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3eb093566213bb85499a3f83bb95b7e0"><gtr:id>3eb093566213bb85499a3f83bb95b7e0</gtr:id><gtr:otherNames>Kalin JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a639fb228c8b4.64456295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>121BC2BD-DDF3-4108-9E8D-837D942E8655</gtr:id><gtr:title>Insights into the activation mechanism of class I HDAC complexes by inositol phosphates.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c836e8ecb1cd6f062737bb1cc96a1f5b"><gtr:id>c836e8ecb1cd6f062737bb1cc96a1f5b</gtr:id><gtr:otherNames>Watson PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d3fef106db1.22356400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2EE3E71-E5F3-4CA4-82BB-930963EFA11A</gtr:id><gtr:title>Recombinant protein expression for structural biology in HEK 293F suspension cells: a novel and accessible approach.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1b54e81452adce05c15733ee9607838"><gtr:id>b1b54e81452adce05c15733ee9607838</gtr:id><gtr:otherNames>Portolano N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>546394b95535e0.88410345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A4123A0-B8EB-4992-BFD1-063B1CDEB4FB</gtr:id><gtr:title>Class I HDACs share a common mechanism of regulation by inositol phosphates.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/345fba85d7717caf1056a737fa6e15cc"><gtr:id>345fba85d7717caf1056a737fa6e15cc</gtr:id><gtr:otherNames>Millard CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_14947_27_23791785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>000759D0-8193-4104-B9D2-12EDD69C8FEF</gtr:id><gtr:title>Targeting Class I Histone Deacetylases in a &amp;quot;Complex&amp;quot; Environment.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/345fba85d7717caf1056a737fa6e15cc"><gtr:id>345fba85d7717caf1056a737fa6e15cc</gtr:id><gtr:otherNames>Millard CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>5a3512a58b82e0.10669617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AF474AD-D4A9-42C5-A884-EAE711F4385C</gtr:id><gtr:title>The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb3a0859e64501e8d11b2ab8a474b61b"><gtr:id>fb3a0859e64501e8d11b2ab8a474b61b</gtr:id><gtr:otherNames>Kelly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>546394b9325972.30314309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43480B24-A8AA-4CE6-9976-0E7C83478E74</gtr:id><gtr:title>A specific mutation in TBL1XR1 causes Pierpont syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a7785adbdbb2beccab5cddbe094e3c6"><gtr:id>3a7785adbdbb2beccab5cddbe094e3c6</gtr:id><gtr:otherNames>Heinen CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>5a35f5d92c6917.95154415</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J009598/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>C23BE70F-1EF6-4CC7-88B0-841CB18DD875</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Genetics &amp; development</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>649031FD-C21E-42D9-AC12-41ACA59CC11C</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biochemistry &amp; physiology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>B6EF57B2-8ACD-48E6-9B45-98507446B053</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Epigenetics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>9031EBB8-791D-4466-9E80-80F98BCB26E1</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Protein expression</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>CF8D454F-63BF-45A6-8974-473A3150758A</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Stem cell biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F14C04A0-571D-4298-AEAC-AEC5A0A9DB7D</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Structural Biology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>